Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

sanofi s.r.l. - bleomicina - bleomicina

Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - calcio levofolinato - calcio levofolinato

Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

alfasigma s.p.a. - calcio levofolinato - calcio levofolinato

Európai Unió - olasz - EMA (European Medicines Agency)

novartis europharm limited - ruxolitinib (come fosfato) - myeloproliferative disorders; polycythemia vera; graft vs host disease - agenti antineoplastici - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. policitemia vera (pv)jakavi è indicato per il trattamento di pazienti adulti affetti da policitemia vera, che sono resistenti o intolleranti di hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.

Svájc - olasz - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - acido folinicum - iniezione/infusione - acidum folinicum 30 mg ut calcii folinas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 3 ml. - antidoto contro folsäureantagonisten - antidota

Svájc - olasz - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - acido folinicum - iniezione/infusione - acidum folinicum 50 mg ut calcii folinas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml. - antidoto contro folsäureantagonisten - antidota

Svájc - olasz - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - acido folinicum - iniezione/infusione - acidum folinicum 100 mg ut calcii folinas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 10 ml. - antidoto contro folsäureantagonisten - antidota

Svájc - olasz - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - acido folinicum - iniezione/infusione - acidum folinicum 200 mg ut calcii folinas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 20 ml. - antidoto contro folsäureantagonisten - antidota

Svájc - olasz - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - acido folinicum - iniezione/infusione - acidum folinicum 350 mg ut calcii folinas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 35 ml. - antidoto contro folsäureantagonisten - antidota

Svájc - olasz - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - acido folinicum - iniezione/infusione - acidum folinicum 500 mg ut calcii folinas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 50 ml. - antidoto contro folsäureantagonisten - antidota